Larvol Delta - Byondis-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-Novel-SIRPDirected-Monoclonal-Antibody-BYON4228-in-Patients-With-Advanced-or-Metastatic-Solid-Tumors

BYON4228 - Byondis

https://www.businesswire.com/news/home/20250603807653/en/Byondis-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-Novel-SIRP-Directed-Monoclonal-Antibody-BYON4228-in-Patients-With-Advanced-or-Metastatic-Solid-Tumors

Jun 3, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next